Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics

K Brassington, S Selemidis, S Bozinovski… - Clinical …, 2022 - portlandpress.com
Chronic obstructive pulmonary disease (COPD) and atherosclerosis are chronic irreversible
diseases, that share a number of common causative factors including cigarette smoking …

[HTML][HTML] The role of smoking in the mechanisms of development of chronic obstructive pulmonary disease and atherosclerosis

S Kotlyarov - International Journal of Molecular Sciences, 2023 - mdpi.com
Tobacco smoking is a major cause of chronic obstructive pulmonary disease (COPD) and
atherosclerotic cardiovascular disease (ASCVD). These diseases share common …

Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients

HR Whittaker, C Bloom, A Morgan… - European …, 2021 - Eur Respiratory Soc
Accelerated lung function decline has been associated with increased risk of cardiovascular
disease (CVD) in a general population, but little is known about this association in chronic …

[HTML][HTML] Reduced lung function and cause-specific mortality: A population-based study of Norwegian men followed for 26 years

L Cestelli, A Gulsvik, A Johannessen, K Stavem… - Respiratory …, 2023 - Elsevier
Background and aim Reduced lung function is associated with increased mortality, but it is
unclear how different spirometric patterns are related to specific deaths. Aim of this study …

Respiratory effects of treatment with a glucagon-like peptide-1 receptor agonist in patients suffering from obesity and chronic obstructive pulmonary disease

AD Altintas Dogan, O Hilberg, S Hess… - … journal of chronic …, 2022 - Taylor & Francis
Purpose Chronic obstructive pulmonary disease (COPD) affects millions of people
worldwide. Obesity is commonly seen concomitantly with COPD. People with COPD have …

[HTML][HTML] Analysis of the Comorbid Course of Chronic Obstructive Pulmonary Disease

S Kotlyarov - Journal of Personalized Medicine, 2023 - mdpi.com
(1) Background. Chronic obstructive pulmonary disease (COPD) has a heterogeneous
natural history, manifested both in the variability of clinical features and in association with …

Inhaled corticosteroid withdrawal and change in lung function in primary care patients with chronic obstructive pulmonary disease in England

HR Whittaker, K Wing, I Douglas, SJ Kiddle… - Annals of the …, 2022 - atsjournals.org
Rationale: In chronic obstructive pulmonary disease (COPD), inhaled corticosteroids (ICS)
are associated with pneumonia, highlighting the importance of investigating subgroups of …

[HTML][HTML] COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV1 – a post-hoc analysis of pooled data

CS Chai, DLC Ng, S Bt Mos, MAB Ibrahim… - BMC Pulmonary …, 2023 - Springer
Background Management strategies of chronic obstructive pulmonary disease (COPD) need
to be tailored to the forced expiratory volume in one second (FEV1), exacerbations, and …

[HTML][HTML] All-cause and cardiovascular mortality in relation to lung function in the full range of distribution across four Eastern European cohorts

T Sarycheva, N Capkova, A Pająk, S Malyutina… - Scientific Reports, 2022 - nature.com
It is unclear whether the dose–response relationship between lung function and all-cause
and cardiovascular mortality in the Central and Eastern European populations differ from …

[HTML][HTML] Association of lung function with the risk of cardiovascular diseases and all-cause mortality in patients with diabetes: Results from NHANES III 1988-1994

N Huang, C Tang, S Li, W Ma, X Zhai, K Liu… - Frontiers in …, 2022 - frontiersin.org
Objective The potential effects of pulmonary dysfunction on cardiovascular diseases (CVD)
and all-cause mortality are receiving attention. The current study aimed to explore whether …